Passive Sensing Technology for Lapse Measurement
Applying Novel Passive Sensing Technology to Target Adherence to Diet in Behavioral Obesity Treatment for Patients With Cardiovascular Disease Risk
1 other identifier
interventional
32
1 country
1
Brief Summary
Behavioral obesity treatment (BOT) produces clinically significant weight loss and health benefits for many individuals with overweight/obesity and cardiovascular disease (CVD). Yet, about half of patients fall short of expected outcomes and most experience gradual weight regain, thus negating the benefits over time. Lapses (i.e., self-reported eating instances that deviate from the BOT prescribed diet) could explain poor outcomes, but the behavior is understudied because it is difficult to assess in-lab and via self-report. The investigators therefore propose to study lapses using a multimethod approach with the following tools: ecological momentary assessment (EMA; repeated sampling method via mobile device), a wrist-worn device that automatically detects eating behavior and various eating characteristics (frequency, rate, and duration of eating episodes), and 24-hour dietary recalls. The investigators will recruit participants (n=40) with overweight/obesity and one additional CVD risk factor to enroll in a 12-week BOT program and an additional 12-week period of weight loss maintenance. Participants will complete a biweekly 7-day EMA protocol to self-report on eating behavior, including the occurrence of dietary lapse. Participants will continuously wear the wrist-worn ActiGraph Link to characterize eating behavior. Lastly, participants will complete 24-hour dietary recalls via structured interview (split between days with and without lapses) at 6-week intervals to measure the composition of all food and beverages consumed. This study aims to 1) identifying characteristics of lapse behavior by measuring passively-sensed timing, duration, frequency, and rate of eating amongst known lapse episodes, 2) test the association between dietary lapse frequency and weight change, and 3) estimate nutrition composition of dietary lapses. The study approach is consistent with priorities of NHLBI to optimize clinical research and diagnostic strategies to improve CVD and related risk factors.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Oct 2018
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
October 24, 2018
CompletedFirst Submitted
Initial submission to the registry
November 8, 2018
CompletedFirst Posted
Study publicly available on registry
November 13, 2018
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 15, 2020
CompletedStudy Completion
Last participant's last visit for all outcomes
September 15, 2020
CompletedMarch 5, 2021
March 1, 2021
1.9 years
November 8, 2018
March 2, 2021
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Sensor-based Dietary Lapse
Participants will wear a wrist-worn 9-axis accelerometer during waking hours that measures wrist-roll motion, which can objectively assess dietary lapses.
24-week frequency of sensor-based dietary lapse
Secondary Outcomes (3)
Self-reported Dietary Lapse
Participants will be asked to complete 7 days of EMA on a biweekly basis for 24 weeks. Therefore, participants will complete EMA at weeks 1, 3, 5, 7, 9, 11, 13, 15, 17, 19, 21, and 23.
Weight
Weight will be measured at each study appointment (baseline assessment, weekly for 12 weeks, and twice monthly for the subsequent 12 weeks).
Dietary Composition
Dietary composition will be assessed at baseline and at weeks 5, 11, 17, and 23
Study Arms (1)
Behavioral Obesity Treatment
OTHERAll participants will receive gold-standard behavioral obesity treatment
Interventions
Self-monitoring. Participants will be taught to record their weight, the calories of each food item, and physical activity using a method of their choice (e.g., commercial smartphone app, paper diary). The clinician will review dietary intake and provide personalized feedback at the outset of session. Diet. Per national guidelines for weight loss, a daily goal of 1200-1800 kcal/day will be prescribed depending on baseline weight. A Mediterranean diet will be prescribed to meet the recommended calorie goal and be consistent with dietary recommendations for CVD patients. Exercise. Participants will be encouraged to achieve 250 minutes/week of moderate intensity activity in accordance with current national recommendations for physical activity among individuals attempting weight loss. Participants will be encouraged to gradually increase activity level to achieve approximately 50 minutes of activity over five days per week.
Eligibility Criteria
You may qualify if:
- Overweight or obesity (body mass index 25-45 kg/m2)
- Interested and able to participate in in-person weight loss intervention
- Physician-diagnosed one or more CVD risk factors (type 2 diabetes/prediabetes, hypercholesterolemia, or hypertension).
You may not qualify if:
- Report health problems that preclude weight loss or physical activity
- Are currently pregnant or breastfeeding, or planning to be pregnant within the next 6 months,
- Are currently or recently (\< 6 months) enrolled in a commercial weight loss program
- Have lost ≥ 5% of their initial body weight in the last 6 months
- Currently taking weight loss medication
- Have had a previous surgical procedure for weight loss
- Have a history of a clinically diagnosed eating disorder excluding Binge Eating Disorder
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
The Miriam Hospital Weight Control and Diabetes Research Center
Providence, Rhode Island, 02909, United States
Related Publications (3)
Goldstein SP, Olson KL, Thomas JG. Association of weight and shape concern with weight change and weight-related behaviors in behavioral weight loss treatment. J Behav Med. 2023 Dec;46(6):1049-1056. doi: 10.1007/s10865-023-00451-5. Epub 2023 Sep 23.
PMID: 37740874DERIVEDGoldstein SP, Hoover A, Thomas JG. Combining passive eating monitoring and ecological momentary assessment to characterize dietary lapses from a lifestyle modification intervention. Appetite. 2022 Aug 1;175:106090. doi: 10.1016/j.appet.2022.106090. Epub 2022 May 20.
PMID: 35598718DERIVEDGoldstein SP, Hoover A, Evans EW, Thomas JG. Combining ecological momentary assessment, wrist-based eating detection, and dietary assessment to characterize dietary lapse: A multi-method study protocol. Digit Health. 2021 Feb 2;7:2055207620988212. doi: 10.1177/2055207620988212. eCollection 2021 Jan-Dec.
PMID: 33598309DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY CHAIR
Graham Thomas, PhD
The Miriam Hospital
- PRINCIPAL INVESTIGATOR
Stephanie P Goldstein, PhD
The Miriam Hospital
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- OTHER
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Associate Professor (Research)
Study Record Dates
First Submitted
November 8, 2018
First Posted
November 13, 2018
Study Start
October 24, 2018
Primary Completion
September 15, 2020
Study Completion
September 15, 2020
Last Updated
March 5, 2021
Record last verified: 2021-03